Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in pediatric basilar/hemiplegic migraine
NCT00131443Phase 3Completed
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of topiramate in migraine with brainstem aura (MBA) and hemiplegic migraine (HM) (2 arms). Primary endpoint: Reduction in average monthly migraine-days. Started Feb 2004; status: completed.
02
Drugs
topiramate
03
Conditions
migraine with brainstem aura (MBA)hemiplegic migraine (HM)
Beyond the preview
Go deeper on NCT00131443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131443.